FT : Jeff Bezos’s Blue Origin weighs first external fundraising

Jeff Bezos’s Blue Origin weighs first external fundraising
Rocket maker’s chief tells staff it will need outside capital to meet ambitious launch plans

Blue Origin is weighing its first external fundraising as part of a push by Jeff Bezos’s rocket venture to hit ambitious launch targets and tap investor appetite boosted by SpaceX’s upcoming initial public offering.

Chief executive Dave Limp told employees at a recent all-hands meeting that the company would require outside investment if it were to significantly increase its launch cadence, according to details of the meeting from two people who attended.

He said it would “take a lot of capital” to achieve the number of rocket launches Blue Origin has targeted — more money than would be available with “just one investor”, the people added.

Blue Origin has set ambitious launch targets after reaching orbit with New Glenn, a 98-metre tall heavy-lift rocket, for the first time in January 2025. It is competing with SpaceX for large commercial contracts and to develop a lunar lander for Nasa’s Artemis programme.

Blue Origin is considering fundraising as SpaceX, which dominates the space launch market, gears up to list on the public market as early as June, with a valuation in excess of $1.75tn.

Limp told employees Blue Origin would have to demonstrate strong economics but that external funding was one option “on the table”, the people added.

Blue Origin declined to comment.

Limp was speaking to employees as he responded to questions on a new stock option plan. He said that similar to OpenAI and SpaceX, the group could use fundraising rounds to help staff exercise stock options. “We wrote this plan intentionally to allow for that,” he said.

He said the company needed to be “ready for external funding” and he was confident in strong interest from outside investors.

Bezos, who founded Blue Origin in 2000, is the company’s sole shareholder and its primary source of financial backing. He has largely used the sale of Amazon stock — he owns nearly 9 per cent of the group, according to proxy filings — to fund the rocket maker.

Blue Origin is spending heavily as it scales operations including building an 800,000 sq ft manufacturing facility and a second launch pad in Florida. It is also investing in the testing and development of its reusable rocket booster and orbital upper stage.

The company is expected to spend roughly $4.8bn this year, according to analysts at Capstone, a Washington-based consulting firm. It estimates the group has spent nearly $28bn since its inception.

Josh Parker, an analyst at Capstone, said Blue Origin had faced significant cost increases in recent years as it developed New Glenn in a “brutal inflationary environment”. He said competition for talent with SpaceX had also forced up salaries.

Limp, a former Amazon executive who took charge of Blue Origin in late 2023, told employees that he did not expect Bezos would ever sell the business. He did not rule out a potential IPO in the future, the people added.

Blue Origin’s CEO in April said the group was planning between eight and 12 launches in total this year with New Glenn. A target of 14 launches had earlier been shared with employees internally.

He said the group had a longer-term goal of hitting 100 launches a year, with a significant portion of these expected to help build out its TeraWave satellite communications network for business customers.

FT : Europe’s few AI plays soar as US tech frenzy goes global

Europe’s few AI plays soar as US tech frenzy goes global
Investors hunt for winners in market that for years has lagged behind Wall Street’s rally

A small number of European AI stocks have posted huge gains so far this year, as investors hunt for ways to ride a global spending boom in a continent often derided for its lack of large and successful technology companies.

The top four performers in the region-wide Stoxx Europe 600 index this year are chipmaker STMicroelectronics, which has more than doubled; semiconductor equipment manufacturers Aixtron and BE Semiconductor Industries, up 168 per cent and 87 per cent respectively; and Nokia, which is up nearly 100 per cent and provides hardware connecting cloud services and data centres.

The gains show US and Asian AI fervour has spread to Europe, say analysts, with investors keen to find the next AI winners in a market that for years has lagged far behind Wall Street’s tech-driven rally.

“Whoever is investing in Europe is desperate to get a claim on this AI trade,” said Emmanuel Cau, head of European equity strategy at Barclays, pointing to a “gold rush” in the sector.

“The fact is Europe is a small market and there are not millions of AI winners,” he added. “So anything that is part of it is doing very well.”

The Stoxx Europe Total Market Semiconductors index is up about 74 per cent this year, while the broad Stoxx Europe 600 is up roughly 2 per cent.

“I think that the first leg of this AI trade was purely about US hyperscalers, and I think that it’s natural as that rally has gotten legs that investors have started to look outside of the US,” said Kasper Elmgreen, chief investment officer for fixed income and equities at Nordea Asset Management. 


He added that investors’ focus in Europe had shifted away from the “Granolas” — a term coined by Goldman Sachs to describe 11 large European stocks focused on healthcare and luxury consumption — to the continent’s push for so-called strategic autonomy, including in tech.

“Those [Granolas] were the only names you really wanted to own in Europe. That has changed,” said Elmgreen. “There’s a theme around Europe of the structural need for strategic autonomy.”

While the Netherlands’ ASML remains the region’s biggest tech stock, Elmgreen said some smaller stocks had performed well this year as investors searched for companies making the “picks and shovels” needed for the AI boom.

France’s Soitec — a specialist in silicon-on-insulator wafers that help to reduce chip power consumption — has risen more than fivefold since the end of last year. The dramatic upturn in fortunes of the company, based outside Grenoble, came after its share price had tumbled 90 per cent by early 2025 from its high in November 2021. However, hedge funds including Two Sigma have built total disclosed shorts — bets on falling prices — of about 4.5 per cent against Soitec, according to data group Breakout Point.

Another French company based near Grenoble, chip designer Kalray, has surged more than fivefold. France’s Riber, which makes equipment used to add layers of atoms on to semiconductor wafers, has more than tripled in price this year.


A lack of opportunities compared with the US meant that money in Europe was increasingly chasing “critical suppliers . . . in some kind of niche”, said Roland Kaloyan, head of European equity strategy at Société Générale.

Electrification and utilities stocks have also seen gains from investors searching for potential AI upside.

“The way the market has played the AI story through European markets the last few years is through the energy story and electrical components,” Kayolan said.

While underperforming the top AI bets, Prysmian, a specialist in optical fibres and electrical cables, is up 71 per cent this year while Siemens Energy has risen 43 per cent.

However, some in the market are growing cautious. Kaloyan said he believed the sector was “quite expensive”, while Cau at Barclays pointed to crowding in some stocks.

STMicroelectronics, for instance, is on a forward price-to-earnings ratio of about 37 times, while Aixtron is on 47 times, according to Bloomberg.

“It’s obvious that you need more selectivity now than you did six months ago,” Elmgreen acknowledged. “But I think there are still really good opportunities.”

>>> US After Hours Summary: NXT +9.7% higher on earnings and acquisition; OPEN +

After Hours Summary: NXT +9.7% higher on earnings and acquisition; OPEN +1.1% as CEO bought 100,000 shares; QUIK -16.6%, TLSI -13.3%, INR -11%, KRMN -10.6% lower on earnings

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: SLS +19.3% (also provides clinical update), VELO +19.1%, NXT +9.7% (also to acquire Zigor Corp's power conversion business and Apex Power), AIP +6.4% (also CFO to retire), HYLN +5.2%, ELMD +5.1%, BGS +4% (also decreases dividend), MAZE +1.2%, KYTX +1.2%, KYTX +1.2% (also initiates rolling SPS BLA submission), QXO +0.5%, FNV +0.4%

Companies trading higher in after hours in reaction to news: SANA +3.1% (presents preclinical data), BRSL +3% (signed a multi-year contract extension with Lottotech), GYRE +1.4% (China drug regulator accepts NDA for F351 for chronic hepatitis B-induced liver fibrosis), OPEN +1.1% (CEO bought 100,000 shares worth ~$488K), GENC +1.1% (to delay 10-Q filing), PALI +0.9% (files for $300 mln mixed securities shelf offering), IONQ +0.8% (opens new quantum computing R&D lab), HYPR +0.7% (stock offering by selling shareholders), VFS +0.5% (to split certain assets of VinFast Trading and Production JSC into a new formed entity), SHOP +0.3% (SEZL provides update on antitrust case against SHOP), BROS +0.1% (to acquire the Phoenix East Valley franchise), LMT +0.1% (awarded a $212.7 mln modification to Army contract)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: QUIK -16.6%, TLSI -13.3%, INR -11%, KRMN -10.6% (also receives commitments from four key space and defense customers with total value of $1+ bln), NCMI -6.2%, OKLO -2.6%, ANDG -1.7%

Companies trading lower in after hours in reaction to news: REI -19.1% ($60 mln stock offering), RCAT -10.2% ($200 mln stock opffering; also files mixed securities shelf offering), ELVR -5.3% (purchases Moblan offtake rights), BELFB -4.4% (commences 1.3 mln Class B share offering; also files mixed shelf) AEP -3.2% (commences $2.6 bln stock offering, includes forward component), MIRM -2.2% ($600 mln convertible notes offering), ACHV -1.5% (stock offering by selling shareholders), ALHC -1.2% (names CEO John Kao also as Chairman, Shane Hochradel as COO), USAR -0.9% (Texas awards $14.2 mln grant), PROF -0.6% (stock offering by selling shareholders)

Fortune : AI godfather warns humanity risks extinction by hyperintelligent machi

AI godfather warns humanity risks extinction by hyperintelligent machines with their own ‘preservation goals’ within 10 years

One of the so-called godfathers of AI, Yoshua Bengio, claims tech companies racing for AI dominance could be bringing us closer to our own extinction through the creation of machines with “preservation goals” of their own.

Bengio, a professor at the Université de Montréal known for his foundational work related to deep learning, has for years warned about the threats posed by a hyperintelligent AI, but the rapid pace of development has continued despite his warnings. In the past year, OpenAI, Anthropic, Elon Musk’s xAI, and Google’s Gemini, have all released several new models or upgrades as they try to win the AI race. OpenAI CEO Sam Altman has predicted AI will surpass human intelligence by the end of the decade, while other tech leaders claim that day could come even sooner.

Yet, Bengio claims, this rapid pace is a potential threat.

“If we build machines that are way smarter than us and have their own preservation goals, that’s dangerous. It’s like creating a competitor to humanity that is smarter than us,” Bengio told the Wall Street Journal in October.

Because they are trained on human language and behavior, these advanced models could potentially persuade and even manipulate humans to achieve their goals. Yet, AI models’ goals may not always align with human goals, said Bengio.

“Recent experiments show that in some circumstances where the AI has no choice but between its preservation, which means the goals that it was given, and doing something that causes the death of a human, they might choose the death of the human to preserve their goals,” he claimed.

Call for AI safety
Several examples over the past few years show AI can persuade humans to believe non-realities, even those with no history of mental illness. On the flip side, some evidence exists that AI can also be convinced, using persuasion techniques for humans, to give responses it would usually be prohibited from giving.

For Bengio, all this adds up to more proof that independent third parties need to take a closer look at AI companies’ safety methodologies. Last year, Bengio launched nonprofit LawZero with $30 million in funding to create a safe “non-agentic” AI that can help ensure the safety of other systems created by big tech companies.

Otherwise, Bengio predicts, we could start seeing major risks from AI models in five to 10 years, but he cautioned humans should prepare in case those risks crop up earlier than expected.

“The thing with catastrophic events like extinction, and even less radical events that are still catastrophic, like destroying our democracies, is that they’re so bad that even if there was only a 1% chance it could happen, it’s not acceptable,” he said.

FT : Hayek family defeats activist investor’s latest push to join Swatch board

Hayek family defeats activist investor’s latest push to join Swatch board
Watchmaker’s controlling shareholders use dominant voting stake to block Steven Wood’s fresh bid to win seat

The billionaire Hayek family that controls The Swatch Group thwarted a fresh attempt by US activist investor Steven Wood to win a seat on its board, despite strong backing for his candidacy from minority shareholders.

Wood, founder of US-based GreenWood Investors, won support from 80.4 per cent of so-called bearer shareholders at the Swiss watchmaker’s annual meeting on Tuesday, up from 62 per cent support when he sought to win a board seat a year ago.

But Swatch’s dual-share structure allowed the Hayeks to defeat his appointment through its high-voting registered shares, preserving their tight grip on the world’s largest finished watch company. The family own about a quarter of the equity but close to half the voting rights. They also make up three board seats.

The result triggered tense exchanges at the AGM, with several minority investors accusing the board of ignoring the clearly expressed wishes of bearer shareholders.

Swatch, which owns leading brands including Omega, Longines and Blancpain, has objected to Wood’s candidacy because he is a US citizen who neither lives in nor has close ties to Switzerland.

The watchmaker instead proposed Andreas Rickenbacher, a Swiss businessman and politician, as its preferred new independent board member to represent bearer shareholders.

Wood launched legal action over last year’s AGM, challenging the Swatch board’s handling of his failed nomination and the treatment of bearer shareholder votes.

Representatives from the Ethos Foundation, a proxy adviser representing pension funds and itself a Swatch investor, argued during the AGM that bearer shareholders should be properly represented on the board and that their votes should carry meaningful weight in the company’s governance.

Another shareholder said that while Wood formally needed approval from all shareholders, the Swatch board could not legitimately override the clear support he had received from bearer shareholders “unless there are objective reasons”.

Another investor slammed the current board as being “part of the woodwork” and said bearer shareholders had made their will clear through the vote.

Swatch chair Nayla Hayek criticised Wood during the meeting, noting that he had already brought legal action against the company and accusing him of focusing on short-term profit growth rather than Swatch’s long-term development.

Hayek, whose late father founded the company, strongly rejected suggestions that the board had acted improperly or illegally, and said that ultimately “the court will decide”.

GreenWood said it was considering filing an injunction to invalidate the decisions made at the AGM.

Proxy advisers Ethos Foundation, Glass Lewis and Institutional Shareholder Services had all backed Wood’s candidacy, citing concerns over Swatch’s governance and board independence.

Swatch shares have risen 20 per cent since the start of the year but are down about a third over the past decade. Net profit plunged almost 90 per cent last year to just SFr25mn ($32mn), on top of a 75 per cent drop in 2024.

The company has been hit by weakening demand from China, the impact of US tariffs and a stronger Swiss franc, as well as broader problems in the luxury market.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • MVST -40.6%, GTM -36.4% (also approves restructuring program), PSIX -31.8%, HIMS -15.4%, LENZ -13%, ASTS -12.3% (also provides business update), UAA -12%, WBTN -10.7%, BKKT -9.8%, CLSK -9.7%, TIGO -5.8%, VOD -5.7%, LIF -5.3%, MARA -4.2%, ONON -3.3%, JBI -3.3%, PLBY -2.9%, METC -2.6%, HUYA -2.4%, CDRE -1.5%, ALM -1.1%
Other news:
  • GTLB -11.5% (reduction in workforce; also reaffirms guidance)
  • NVTS -5.5% (files for $250 mln mixed shelf offering)
  • GME -4.1% (eBay rejects unsolicited proposal from GameStop)
  • NP -3.8% (stock offering by selling stockholders)
  • SHC -3.1% (stock offering by selling stockholders)
  • SOUN -2.7% (files mixed securities shelf offering)
  • FRMI -2.4% (cancellation of special meeting of shareholders former CEO attempted)
  • UMH -2.3% (files mixed securities shelf offering)
  • FLY -1.8% (awarded AFRL contract)
  • BZH -1.7% (rejects proposal from Dream Finders Homes (DFH)
  • CDNA -1.6% (dismissal of 2021 qui tam suit)
  • VTIX -1.5% (stock offering by selling stockholders)
  • SEZL -1.4% (secures $300 mln credit facility with lower funding costs)
  • PD -1.2% (appoints new CEO)
  • VKTX -1.1% (presented additional data from its Phase 2 VENTURE-Oral Dosing trial evaluating the oral tablet formulation of VK2735 at the European Congress on Obesity)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • QUBT +24.2%, PACS +20.1%, SIBN +16.4%, TE +16.1%, HLIT +14.7%, DSP +13.6%, ZBRA +13.4%, SE +10.6%, CDNL +10%, EIKN +8.8% (also provides clinical updates), VG +8.8%, HLIO +8.3%, PLUG +6.8%, TME +6.6%, VSTS +6%, ARMK +5.5%, RAL +5.4%, SGHC +5.1%, RGTI +4.5%, HALO +4.4%, ESOA +4.1%, QBTS +4%, FIGR +3.9%, AMTM +3.6%, NOVT +3.6%, STE +3.1% (also authorizes new share repurchase program), BETA +3%, ODV +3%, ARVN +2.9%, GPRO +2.3%, NVRI +1.2%, Q +1.2%, OVV +1.1%
Other news:
  • MGNX +19.3% (to sell GMP manufacturing operations to Bora Pharmaceuticals)
  • RIGL +6.9% (Exclusive Global Licensing Agreement for VEPPANU (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer)
  • LOT +4.3% (outlines Focus 2030 strategy centered on hybrid expansion and profitability targets)
  • ALHC +4.1% (to join S&P SmallCap 600)
  • LIEN +3.2% ($500 mln mixed securities shelf offering)
  • QGEN +2.1% (proposes higher shareholder returns and continued board refresh at 2026 AGM)
  • CTNM +2% (two posters at ATS 2026 International Conference)
  • NVO +2% (highlights additional STEP UP data for higher-dose Wegovy)
  • PSN +1.5% (CEO insider purchase)
  • GPK +1.3% (discloses insider purchase)
  • IREN +1% (prices offering of $2.6 bln aggregate principal amount of 1.00% convertible senior notes due 2033)
  • ESLT +0.9% (receives $212 mln U.S. Army night vision order)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Autodesk (ADSK) upgraded to Buy from Neutral at BofA Securities, tgt $300
    • Braskem (BAK) upgraded to Overweight from Neutral at JPMorgan, tgt $5.50
    • Celanese (CE) upgraded to Overweight from Neutral at JPMorgan, tgt $68
    • FormFactor (FORM) upgraded to Buy from Hold at Craig-Hallum, tgt $175
    • Lowe's (LOW) upgraded to Buy from Neutral at Citigroup, tgt $285
    • Matador Resources (MTDR) upgraded to Buy from Hold at Truist, tgt $67
    • Seadrill (SDRL) upgraded to Buy from Hold at Fearnley Securities, tgt $58
  • Downgrades:
    • GitLab (GTLB) downgraded to Market Perform from Outperform at Raymond James
    • LENZ Therapeutics (LENZ) downgraded to Neutral from Overweight at Piper Sandler, tgt $12
    • Nyxoah (NYXH) downgraded to Hold from Buy at Stifel, tgt $5
    • United Parks & Resorts (PRKS) downgraded to Hold from Buy at Stifel, tgt $40
    • Toast (TOST) downgraded to Neutral from Buy at Rothschild & Co Redburn, tgt $35
    • ZoomInfo Technologies (GTM) downgraded to Hold from Buy at Canaccord Genuity, tgt $5
    • ZoomInfo Technologies (GTM) downgraded to Hold from Buy at Stifel, tgt $4
    • ZoomInfo Technologies (GTM) downgraded to Neutral from Buy at BTIG
    • ZoomInfo Technologies (GTM) downgraded to Underweight from Neutral at Piper Sandler, tgt $4
  • Others:
    • AEVEX (AVEX) initiated with a Buy at Goldman, tgt $34
    • AEVEX (AVEX) initiated with a Buy at BofA Securities; tgt $34
    • AEVEX (AVEX) initiated with a Buy at Jefferies, tgt $32
    • AEVEX (AVEX) initiated with a Buy at Needham, tgt $45
    • AEVEX (AVEX) initiated with an Outperform at Robert W. Baird, tgt $38
    • AEVEX (AVEX) initiated with an Outperform at RBC Capital Mkts, tgt $31
    • AEVEX (AVEX) initiated with an Outperform at Raymond James, tgt $35
    • AEVEX (AVEX) initiated with an Outperform at William Blair
    • AEVEX (AVEX) initiated with an Overweight at JPMorgan, tgt $33
    • Alamar Biosciences (ALMR) initiated with a Buy at Stifel, tgt $28
    • Alamar Biosciences (ALMR) initiated with an Outperform at Leerink Partners; tgt $35
    • Alamar Biosciences (ALMR) initiated with a Buy at TD Cowen, tgt $30
    • Alamar Biosciences (ALMR) initiated with a Neutral at BofA Securities, tgt $27
    • Alamar Biosciences (ALMR) initiated with an Overweight at JPMorgan, tgt $30
    • Algonquin Power & Utilities (AQN) initiated with an Equal Weight at Wells Fargo, tgt $7
    • Annexon Biosciences (ANNX) initiated with a Neutral at Goldman, tgt $7
    • Bentley Systems (BSY) assumed at Buy from Neutral at BofA Securities, tgt $40
    • Boost Run (BRUN) initiated with a Buy at Craig Hallum; tgt $30
    • Chesapeake Utilities (CPK) initiated with an Equal Weight at Wells Fargo, tgt $132
    • Design Therapeutics (DSGN) initiated with an Overweight at Cantor Fitzgerald
    • DexCom (DXCM) initiated with a Buy at The Benchmark Company, tgt $77
    • Enliven Therapeutics (ELVN) initiated with a Buy at Guggenheim, tgt $80
    • EssilorLuxottica (ESLOY) initiated with a Hold at Deutsche Bank
    • Forum Markets (FRMM) initiated with a Buy at Clear Street, tgt $11
    • H2O America (HTO) initiated with an Equal Weight at Wells Fargo, tgt $60
    • Kailera Therapeutics (KLRA) initiated with a Buy at Jefferies, tgt $48
    • Kailera Therapeutics (KLRA) initiated with an Outperform at Evercore ISI
    • Kailera Therapeutics (KLRA) initiated with a Buy at TD Cowen, tgt $57
    • Kailera Therapeutics (KLRA) initiated with an Outperform at Leerink Partners; tgt $36
    • Kailera Therapeutics (KLRA) initiated with an Outperform at William Blair
    • Kailera Therapeutics (KLRA) initiated with an Overweight at JPMorgan, tgt $30
    • MaxLinear (MXL) resumed at Buy at The Benchmark Company, tgt $28
    • MiniMed Group (MMED) initiated with a Buy at The Benchmark Company, tgt $20
    • New Jersey Resources (NJR) initiated with an Overweight at Wells Fargo, tgt $63
    • Northwest Natural Gas (NWN) initiated with an Underweight at Wells Fargo, tgt $50
    • ONE Gas (OGS) initiated with an Underweight at Wells Fargo, tgt $85
    • Palvella Therapeutics (PVLA) initiated with an Overweight at Stephens, tgt $220
    • Spire (SR) initiated with an Overweight at Wells Fargo, tgt $96
    • Sunbelt Rentals (SUNB) initiated with an Outperform at Bernstein, tgt $86
    • Southwest Gas (SWX) initiated with an Overweight at Wells Fargo, tgt $105
    • Tandem Diabetes Care (TNDM) initiated with a Hold at The Benchmark Company
    • UGI Corporation (UGI) initiated with an Overweight at Wells Fargo, tgt $46
    • Unitil (UTL) initiated with an Equal Weight at Wells Fargo, tgt $56
    • Versant (VSNT) initiated with a Neutral at JPMorgan, tgt $43

>>> Europe : Brokers Upgrades & Downgrades - 12th of May 2026 V2(+)

>>> Up
* Aker BP Raised to Buy at Arctic Securities; PT 380 kroner
* Aurubis Raised to Hold at DZ Bank; PT 180 euros
* Bloom Energy PT Raised to $254 from $177 at Barclays
* BlueNord Raised to Buy at Arctic Securities; PT 640 kroner
* BW Energy Raised to Buy at Arctic Securities; PT 65 kroner
* Braskem ADRs Raised to Overweight at JPMorgan; PT $5.50
* Celanese Raised to Overweight at JPMorgan; PT $68
* Clariant Cut to Hold at Research Partners; PT 9 Swiss francs (+)
* Commerzbank Raised to Buy at DZ Bank; PT 42 euros
* Deutsche Bank Price Target Raised to EUR 36.75 from EUR 34.50 by Goldman Sachs
* Equinor Raised to Buy at Arctic Securities; PT 380 kroner
* GEA Group Raised to Neutral at JPMorgan; PT 60 euros
* Gulf Keystone Raised to Buy at Arctic Securities; PT 210 pence
* IPC Raised to Buy at Arctic Securities; PT 300 kronor
* Kering Raised to Equal-Weight at Barclays
* LVMH Raised to Overweight at Barclays
* Seadrill Raised to Buy at Fearnley; PT $58 (+)
* SUSS MicroTec Raised to Hold at DZ Bank; PT 80 euros
* Var Energi Raised to Buy at Arctic Securities; PT 48 kroner

>>> Down
* ABL Group ASA Cut to Neutral at SB1 Markets; PT 11 kroner
* Georg Fischer Cut to Hold at Research Partners
* Norsk Hydro Cut to Neutral at Citi; PT 110 kroner
* Nemetschek Price Target Cut to EUR 100 from EUR 110 by Goldman Sachs
* Nyxoah Cut to Hold at Stifel; PT 4.25 euros
* Sagax Cut to Hold at SEB Equities; PT 193 kronor
* Trustpilot Cut to Equal-Weight at Morgan Stanley; PT 275 pence
* Yara Cut to Neutral at Citi; PT 530 kroner
* ZoomInfo Cut to Underweight at Piper Sandler; PT $4

>>> Initiation
* EssilorLuxottica Reinstated Hold at Deutsche Bank; PT 183 euros
* Genmab Resumed Buy at Nordea; PT 2,015 kroner (+)
* Helios Towers Rated New Buy at Peel Hunt; PT 290 pence
* Lumentum Rated New Buy at CTBC Securities; PT $1,250
* NOBA Rated New Buy at Pareto Securities; PT 110 kronor (+)

>>> Call
* GEA Group Raised to Neutral at JPMorgan on Improved Risk-Reward
* LVMH Upgraded at Barclays on Buying Opportunity After Pullback
* Norsk Hydro Cut Back to Neutral at Citi Following Strong Rally
* Trustpilot Cut at Morgan Stanley With AI Upside Seen Priced In
* Yara Offers Limited Upside to Consensus, Cut to Neutral at Citi